Exhibit
23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
We
consent to the inclusion in the foregoing Post-Effective Amendment
No. 1 on Registration Statement on Form S-1 (File No. 333-251311)
of our report dated April 16, 2021 by reference, relating to the
consolidated financial statements of GT BioPharma, Inc. as of
December 31, 2020, and for the year then ended (which report
includes an explanatory paragraph relating to substantial doubt
about GT BioPharma, Inc.’s ability to continue as a going
concern). We also consent to the reference to our firm under the
caption “Experts”.
Weinberg
& Company, P.A.
Los
Angeles, California
April
22, 2021